Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids

被引:31
作者
Guichardant, M
Bernoud-Hubac, N
Chantegrel, B
Deshayes, C
Lagarde, M
机构
[1] Inst Natl Sci Appl, INSERM U352, F-69621 Villeurbanne, France
[2] Inst Natl Sci Appl Lyon, Lyon, France
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2002年 / 67卷 / 2-3期
关键词
D O I
10.1054/plef.2002.0412
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Hydroxy-nonenal (4-HNE) is a major by-product of n-6 fatty acid peroxidation. It has been described to covalently bind biomolecules expressing primary amine, especially the Lys residues in proteins. Low-density lipoproteins (LDL) are well-described macromolecules to be modified by 4-HNE, making them available to scavenger receptors on macrophages. Those macrophages then become foam cells and play an active role in atherogenesis. This paper reports on the covalent binding of 4-HNE to phosphatidylethanolamine (PE), a major aminophospholipid in biological membranes. In contrast, phosphatidylserine (PS) is virtually not modified by 4-HNE. One stable adduct, the Michael adduct PE/4-HNE is a poor substrate of secreted phospholipase A(2) and is not cleaved by phospholipase D. Plasmalogen PE, an important subclass of PE, is covalently modified by 4-HNE as well, but appears to be further degraded on its sn-1 position, the alkenyl chain, which might alter the antioxidant potential of the molecule. An aldehyde homologous to 4-HNE has been characterized as a breakdown product of 12-hydroperoxyeicosatetraenoic acid (12-HpETE) and named 4-hydroxy-2E,6Z-dodecadienal (4-HDDE). This compound as well as 4-HNE was detected in human plasma. Finally, 4-HDDE appears almost 3-fold more active than 4-HNE to make covalent adducts with PE. We conclude that 4-HNE and 4-HDDE are two biologically relevant markers of n-6 fatty acid peroxidation that may alter the phospholipid-dependent cell signaling. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:147 / 149
页数:3
相关论文
共 15 条
[1]   Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein [J].
AlAbed, Y ;
Liebich, H ;
Voelter, W ;
Bucala, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :2892-2896
[2]   ARACHIDONATE CANNOT BE RELEASED DIRECTLY FROM DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE IN THROMBIN-STIMULATED PLATELETS [J].
COLARD, O ;
BRETON, M ;
PEPIN, D ;
CHEVY, F ;
BEREZIAT, G ;
POLONOVSKI, J .
BIOCHEMICAL JOURNAL, 1989, 259 (02) :333-339
[3]   ENHANCEMENT OF EICOSENOIC ACID LIPOXYGENATION IN HUMAN-PLATELETS BY 12-HYDROPEROXY DERIVATIVE OF ARACHIDONIC-ACID [J].
CROSET, M ;
LAGARDE, M .
LIPIDS, 1985, 20 (11) :743-750
[4]   PLASMALOGEN PHOSPHOLIPIDS AS POTENTIAL PROTECTORS AGAINST LIPID-PEROXIDATION OF LOW-DENSITY LIPOPROTEINS [J].
ENGELMANN, B ;
BRAUTIGAM, C ;
THIERY, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (03) :1235-1242
[5]   Covalent modifications of aminophospholipids by 4-hydroxynonenal [J].
Guichardant, M ;
Taibi-Tronche, P ;
Fay, LB ;
Lagarde, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (09) :1049-1056
[6]   INTERACTION OF 4-HYDROXYNONENAL-MODIFIED LOW-DENSITY LIPOPROTEINS WITH THE FIBROBLAST APOLIPOPROTEIN-B/E RECEPTOR [J].
JESSUP, W ;
JURGENS, G ;
LANG, J ;
ESTERBAUER, H ;
DEAN, RT .
BIOCHEMICAL JOURNAL, 1986, 234 (01) :245-248
[7]  
LAGARDE M, 1995, PROSTAGLANDINS LEUKO, V52, P959
[8]   QUANTITATIVE-DETERMINATION OF THE LIPID-PEROXIDATION PRODUCT 4-HYDROXYNONENAL BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LANG, J ;
CELOTTO, C ;
ESTERBAUER, H .
ANALYTICAL BIOCHEMISTRY, 1985, 150 (02) :369-378
[9]   OXIDIZED LIPOPROTEINS, ALTERED CELL-FUNCTION AND ATHEROSCLEROSIS [J].
PENN, MS ;
CHISOLM, GM .
ATHEROSCLEROSIS, 1994, 108 :S21-S29
[10]   MECHANISMS OF FREE-RADICAL OXIDATION OF UNSATURATED LIPIDS [J].
PORTER, NA ;
CALDWELL, SE ;
MILLS, KA .
LIPIDS, 1995, 30 (04) :277-290